Jun 2026 (Q2 FY26) — Aug 4, 2026
Dorman Products Q2 FY26 — Record Earnings Driven by Tariff Refunds and Strong Cash Flow
Read the full callDorman Products (DORM) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Dorman Products earnings: last reported Tue, 4 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 545 | +0.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 21.3 | +6.1 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 87.8 | +49.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
What management said, and what became of it
9 of 9 judged targets kept · 18 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Large Light Duty customer's ordering patterns stabilize | order fluctuations continue in Q1 2026 with stabilization returning in Q2 2026 | Dec 2025 | that's become more normalized. I believe that was back in the fourth quarter, Jeff, and we've seen more normalized kind of order rates in comparison to sellout | Achieved |
| Full-year adjusted diluted EPS | $8.10 to $8.50 | Dec 2025 | we now expect total adjusted diluted EPS to be in the range of $8.50 to $8.80, up from our prior range of $8.10 to $8.50 | Revised Up |
| Full-year free cash flow returns to normalized levels | operating and free cash flow continue improving, normalizing in the back half of 2026 | Dec 2025 | The business did an excellent job driving working capital improvements, which delivered comparable free cash flow of approximately $62 million, exclusive of the IEEPA refund | On Track |
18 of Dorman Products, Inc.'s 27 targets are still open. See which are on track and which have gone quiet. The 3 above are the free sample; 24 more targets are in the full ledger.
Claimed
- Record adjusted diluted EPS of $3.08, up 50% year-over-year, significantly boosted by IEEPA tariff refunds.
- Strong operating cash flow of $153 million and free cash flow of $144 million, with $62 million comparable free cash flow excluding refunds.
- Light Duty segment operating margin expanded 620 basis points to 24.7%, driven by refund dynamics.
- Successful debt refinancing, expanding revolving credit facility to $800 million and extending maturity to 2031, resulting in $931 million total liquidity.
- Net sales of $545 million, a record for the second quarter, up approximately 1% year-over-year.
Qualified
- Full-year net sales growth guidance reduced from 7-9% to 3-5% due to first-half performance and targeted pricing actions.
- Light Duty segment volume was lower in the quarter, comparing against a strong 10% year-over-year growth in Q2 FY25.
- Heavy Duty segment continues to face challenging market conditions with no meaningful trucking mileage or tonnage growth expected in 2026.
- Specialty Vehicles net sales were down 1% year-over-year due to slightly softer customer demand and sensitive consumer sentiment.
- Modest pressure continued on DIY-focused and relatively discretionary categories within the Light Duty segment.
Price
$123.63 +1.46% · +$1.78
Performance −11.7% 1Y
1Y: $140.06 on 14 Oct 2025 → $123.63. High $158.03 (24 Oct 2025), low $100.5 (6 Apr 2026).
- Previous close
- $121.85
- 52-week range
- $100.5 – $158.03
- One year
- −12.46%
Overview
- Symbol
- DORM
- Sector
- Consumer Discretionary
- Exchange
- US
- Currency
- USD
Guidance
What management said, and what became of it
9 of 9 judged targets kept · 18 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Large Light Duty customer's ordering patterns stabilize | order fluctuations continue in Q1 2026 with stabilization returning in Q2 2026 | Dec 2025 | that's become more normalized. I believe that was back in the fourth quarter, Jeff, and we've seen more normalized kind of order rates in comparison to sellout | Achieved |
| Full-year adjusted diluted EPS | $8.10 to $8.50 | Dec 2025 | we now expect total adjusted diluted EPS to be in the range of $8.50 to $8.80, up from our prior range of $8.10 to $8.50 | Revised Up |
| Full-year free cash flow returns to normalized levels | operating and free cash flow continue improving, normalizing in the back half of 2026 | Dec 2025 | The business did an excellent job driving working capital improvements, which delivered comparable free cash flow of approximately $62 million, exclusive of the IEEPA refund | On Track |
Claimed
- Record adjusted diluted EPS of $3.08, up 50% year-over-year, significantly boosted by IEEPA tariff refunds.
- Strong operating cash flow of $153 million and free cash flow of $144 million, with $62 million comparable free cash flow excluding refunds.
- Light Duty segment operating margin expanded 620 basis points to 24.7%, driven by refund dynamics.
- Successful debt refinancing, expanding revolving credit facility to $800 million and extending maturity to 2031, resulting in $931 million total liquidity.
- Net sales of $545 million, a record for the second quarter, up approximately 1% year-over-year.
Qualified
- Full-year net sales growth guidance reduced from 7-9% to 3-5% due to first-half performance and targeted pricing actions.
- Light Duty segment volume was lower in the quarter, comparing against a strong 10% year-over-year growth in Q2 FY25.
- Heavy Duty segment continues to face challenging market conditions with no meaningful trucking mileage or tonnage growth expected in 2026.
- Specialty Vehicles net sales were down 1% year-over-year due to slightly softer customer demand and sensitive consumer sentiment.
- Modest pressure continued on DIY-focused and relatively discretionary categories within the Light Duty segment.
The full ledger
Open Dorman Products, Inc.’s full ledger
A free account opens 5 company ledgers a month. All 27 tracked commitments, with each call’s wording and source.
Call summaries
Mar 2026 (Q1 FY26) — May 5, 2026
Dorman Products Q1 FY26 — Solid Performance Amidst Tariff Headwinds
Read the full callDec 2025 (Q4 FY25) — Feb 26, 2026
Dorman Products Q4 FY25 — Strong EPS and Strategic Execution Amidst Tariff Headwinds
Read the full callEvery analysed call
Dorman Products earnings calls (DORM)
Financials
What the filings say
Net profit, year on year: +50% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 504 | 534 | 508 | 541 | 544 | 538 | 529 | 545 |
| Operating profit | 79 | 87 | 80 | 82 | 106 | 31 | 59 | 116 |
| Operating margin | 15.7% | 16.3% | 15.8% | 15.3% | 19.4% | 5.8% | 11.1% | 21.3% |
| Other income | 2 | 1 | 1 | 2 | 1 | 0 | 3 | 6 |
| Interest | 10 | 9 | 7 | 7 | 7 | 7 | 6 | 6 |
| Profit before tax | 71 | 79 | 74 | 77 | 100 | 25 | 56 | 115 |
| Tax rate | 22.3% | 30.9% | 22.4% | 23.6% | 23.5% | 53.0% | 22.5% | 24.0% |
| Net profit | 55 | 55 | 58 | 59 | 76 | 12 | 44 | 88 |
| EPS ($ per share) | 1.81 | — | 1.88 | 1.92 | 2.50 | — | 1.44 | 2.94 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 679 | 721 | 789 | 856 | 957 | 1,069 | 1,181 | 1,344 |
| Total liabilities | 250 | 267 | 367 | 740 | 1,299 | 1,124 | 1,131 | 1,016 |
| Fixed assets | 99 | 102 | 91 | 115 | 148 | 160 | 164 | 169 |
| Total assets | 978 | 1,041 | 1,221 | 1,673 | 2,342 | 2,292 | 2,425 | 2,493 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 78 | 95 | 152 | 100 | 42 | 209 | 231 | 114 |
| Cash from investing | -59 | -30 | -30 | -365 | -527 | -44 | -39 | -38 |
| Cash from financing | -47 | -41 | -34 | 168 | 472 | -174 | -171 | -84 |
| Net cash flow | -28 | 25 | 87 | -97 | -13 | -9 | 20 | -8 |
| Capital expenditure | -26 | -30 | -15 | -20 | -38 | -44 | -39 | -38 |
| Free cash flow | 52 | 66 | 137 | 80 | 4 | 165 | 192 | 76 |
DORM revenue by segment
| Segment | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Light Duty | 78% | 80% | 81% | 78% | 79% | 80% | 80% | 78% | 0.0% |
| Heavy Duty | 12% | 10% | 10% | 11% | 12% | 10% | 11% | 12% | +6.8% |
| Specialty Vehicle | 10% | 10% | 9% | 10% | 9% | 10% | 9% | 10% | -1.0% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Revenue by region
Q2 FY2026 · share of revenue
- Non Us 8%
As DORM cuts its regions in its filings; they can nest, so they need not add to 100%.
Insider filings
92 filings between Oct 31, 2025 and Sep 14, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$3.40M
15 sales by 4 insiders
47% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 24
- Award — granted as compensation
- 9
- Option exercise — converted options into shares
- 43
- Tax withheld — shares kept back by the company to cover tax
Also filed: 1 gift.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Hession David | — | $1.69M | Oct 31, 2025 |
| McKnight John | — | $897.8K | Dec 12, 2025 |
| Bowen Gregory C. | — | $512.0K | Aug 5, 2026 |
| Long Donna M. | — | $297.3K | Aug 17, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Braun Joseph P. SVP and General Counsel | Option exercise | 4,708 | $399.9K |
| Sep 14, 2026 | Braun Joseph P. SVP and General Counsel | Tax withheld | 3,159 | $399.9K |
| Sep 9, 2026 | Olsen Kevin M. President and CEO | Option exercise | 4,749 | $389.6K |
| Sep 9, 2026 | Olsen Kevin M. President and CEO | Tax withheld | 11,923 | $1.51M |
| Sep 9, 2026 | Olsen Kevin M. President and CEO | Option exercise | 11,697 | $721.5K |
| Sep 3, 2026 | Pacheco Kathleen President, Specialty Vehicle | Tax withheld | 201 | $26.1K |
| Aug 17, 2026 | Long Donna M. SVP, CIO | Sale 10b5-1 plan | 734 | $99.2K |
| Aug 5, 2026 | Bowen Gregory C. VP, Chief Accounting Officer | Sale | 1,974 | $286.7K |
| Aug 5, 2026 | Bowen Gregory C. VP, Chief Accounting Officer | Option exercise | 1,557 | $142.1K |
| Aug 5, 2026 | Bowen Gregory C. VP, Chief Accounting Officer | Option exercise | 1,974 | $190.2K |
| Aug 5, 2026 | Bowen Gregory C. VP, Chief Accounting Officer | Sale | 1,557 | $225.3K |
| Jun 2, 2026 | Pacheco Kathleen President, Specialty Vehicle | Tax withheld | 116 | $14.6K |
| Jun 2, 2026 | Bowen Gregory C. VP, Chief Accounting Officer | Tax withheld | 76 | $9.6K |
| Jun 1, 2026 | Bowen Gregory C. VP, Chief Accounting Officer | Award | 215 | $24.9K |
| Jun 1, 2026 | Bachmann Lisa M Director | Award | 1,344 | $164.9K |
| Jun 1, 2026 | BERMAN STEVEN L Director | Award | 1,344 | $164.9K |
| Jun 1, 2026 | RILEY RICHARD T Director | Award | 1,344 | $164.9K |
| Jun 1, 2026 | GAVIN JOHN J Director | Award | 1,344 | $164.9K |
| Jun 1, 2026 | Romano Kelly A Director | Award | 1,344 | $164.9K |
| Jun 1, 2026 | Thomas James Darrell Director | Award | 1,344 | $164.9K |
| Jun 1, 2026 | Stakias G. Michael Director | Award | 1,344 | $164.9K |
| May 15, 2026 | RILEY RICHARD T Director | Tax withheld | 33 | $3.8K |
| May 15, 2026 | Bachmann Lisa M Director | Tax withheld | 33 | $3.8K |
| May 15, 2026 | Romano Kelly A Director | Tax withheld | 33 | $3.8K |
| May 15, 2026 | Thomas James Darrell Director | Tax withheld | 33 | $3.8K |
| Mar 12, 2026 | Long Donna M. SVP, CIO | Sale 10b5-1 plan | 235 | $24.4K |
| Mar 12, 2026 | Long Donna M. SVP, CIO | Sale 10b5-1 plan | 394 | $40.7K |
| Mar 12, 2026 | Long Donna M. SVP, CIO | Sale 10b5-1 plan | 318 | $32.5K |
| Mar 4, 2026 | Braun Joseph P. SVP and General Counsel | Tax withheld | 538 | $62.5K |
| Mar 4, 2026 | Long Donna M. SVP, CIO | Tax withheld | 531 | $61.7K |
| Mar 4, 2026 | Olsen Kevin M. President and CEO | Tax withheld | 2,724 | $316.4K |
| Mar 4, 2026 | Bowen Gregory C. VP, Chief Accounting Officer | Tax withheld | 107 | $12.4K |
| Mar 4, 2026 | Leff Scott SVP, CHRO | Tax withheld | 539 | $62.6K |
| Mar 4, 2026 | Luftig Eric President, Light Duty | Tax withheld | 306 | $35.5K |
| Mar 3, 2026 | Braun Joseph P. SVP and General Counsel | Tax withheld | 304 | $35.3K |
| Mar 3, 2026 | Olsen Kevin M. President and CEO | Tax withheld | 2,072 | $240.8K |
| Mar 3, 2026 | Long Donna M. SVP, CIO | Tax withheld | 221 | $25.7K |
| Mar 3, 2026 | Bowen Gregory C. VP, Chief Accounting Officer | Tax withheld | 76 | $8.8K |
| Mar 3, 2026 | Luftig Eric President, Light Duty | Tax withheld | 277 | $32.2K |
| Mar 3, 2026 | Leff Scott SVP, CHRO | Tax withheld | 235 | $27.3K |
| Mar 3, 2026 | Pacheco Kathleen President, Specialty Vehicle | Tax withheld | 142 | $16.5K |
| Mar 2, 2026 | Olsen Kevin M. President and CEO | Tax withheld | 715 | $82.9K |
| Mar 2, 2026 | Olsen Kevin M. President and CEO | Tax withheld | 508 | $58.9K |
| Mar 2, 2026 | Pacheco Kathleen President, Specialty Vehicle | Award | 1,725 | $200.0K |
| Mar 2, 2026 | Leff Scott SVP, CHRO | Award | 3,234 | $374.9K |
| Mar 2, 2026 | Leff Scott SVP, CHRO | Tax withheld | 92 | $10.7K |
| Mar 2, 2026 | Leff Scott SVP, CHRO | Tax withheld | 67 | $7.8K |
| Mar 2, 2026 | Long Donna M. SVP, CIO | Award | 2,587 | $299.9K |
| Mar 2, 2026 | Long Donna M. SVP, CIO | Tax withheld | 90 | $10.4K |
| Mar 2, 2026 | Long Donna M. SVP, CIO | Tax withheld | 66 | $7.7K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Dorman Products, Inc.
Free account. Everything above stays public.
Write why you follow Dorman Products, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading